The EU Biotech Act is a legislative initiative aimed at simplifying biotech regulation, boosting innovation and investment, and strengthening Europe’s competitiveness and biotech ecosystem, which we…
As the festive season approaches, we want to take a moment to thank everyone who joined us for the Kluwer UPC Christmas Quiz 2025. Your participation and enthusiasm made this year’s quiz a great…
The Brazilian PTO (BRPTO) has just introduced a significant regulatory change affecting patent applications in the field of electric communication technologies. Through Ordinance #17/2025, published…
1 January 2026 marks 30 years since the end of the one-year transitional period for developed country Members of the World Trade Organization (‘WTO’) to apply the provisions of the Agreement on Trade…
Today, I would like to offer a review of Léon Dijkman’s The Proportionality Test in European Patent Law and the UPC, a timely and ambitious contribution to the fast-evolving law of patent remedies in…
BackgroundWe previously set out the background and genesis of the proposed regulatory provisions of the "Proposal for a Directive of the European Parliament and of the Council on the Union Code…
It is increasingly difficult to discuss Intellectual Property (IP) without immediately bumping into questions of Artificial Intelligence (AI). The EU has been busy legislating in this field in recent…
An offer you can refuse?The recent judgment in Teva/Cephalon firmly anchors EU jurisprudence on pay-for-delay agreements. By upholding the sanctions imposed on the two companies for a series of side…
In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions (PTE): Otsuka…
As we celebrate another year of the Unified Patent Court in action and head into the festive season, we invite our readers to put their UPC knowledge to the test in the Kluwer UPC Christmas Quiz 2025…
